Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Brivaracetam 1件: Brivaracetam1件: Brivaracetam 💬 1件: SV2 💬 1件: ECM-receptor interaction 💬2件: 149, 309 💬
2 Cetirizine 3件: Cetirizina; Cetirizine; Cetirizine hydrochloride2件: Cetirizine hydrochloride ,
Cetirizine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬6件: 13, 19, 28, 35, 300, 309 💬
3 Clervonafusp alfa 1件: Clervonafusp alfa1件: Clervonafusp alfa 💬 2件: GAA,
SLC29A1_2_3 💬 		4件: Alcoholism, Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬1件: 309 💬
4 ION283 1件: ION283---1件: 309 💬
5 Ropinirole 2件: Ropinirole; Ropinirole hydrochloride2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 74, 309 💬